Table 1.
Patients’ characteristics, asthmatic disease time, comorbidities related to asthma, radiological severity of bronchiectasis, type of biological therapy prescribed.
| Clinical Feature | |
|---|---|
| Age, year m ± sd | 59.08 ± 11.09 |
| Female sex, % | 50 |
| BMI, kg/m2 m ± sd | 24.86 ± 3.53 |
| Smoker, % | |
| current | 13.9 |
| former | 27.8 |
| never | 58.3 |
| BSI score, m ± sd | 7.09 ± 3.98 |
| Bilateral bronchiectasis yes, % | 84.6 |
| Nodular pattern yes, % | 13.9 |
| Time of asthmatic disease, year m ± sd |
27.52 ± 18.11 |
| Family history of asthma yes, % | 19.4 |
| GERD yes, % | 30.6 |
| ASA sensibility yes, % | 11.1 |
| Allergic rhinitis yes, % | 33.3 |
| LTRA therapy yes, % | 41.7 |
| Biological therapy, % | |
| omalizumab | 16.7 |
| mepolizumab | 63.9 |
| bernalizumab | 19.4 |
BMI: body mass index; BSI: bronchiectasis severity index; GERD: gastro-esophageal reflux disease; ASA sensibility: acetylsalicylic acid sensibility; LTRA: leukotriene receptor antagonist.